{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:38:01Z","timestamp":1790858281874,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":3690,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.exphem.2012.01.004","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T10:28:51Z","timestamp":1326191331000},"page":"367-378.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["ABT-737 increases tyrosine kinase inhibitor\u2013induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34+ CD38\u2212 population to imatinib"],"prefix":"10.1016","volume":"40","author":[{"given":"Kelly","family":"Airiau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Xavier","family":"Mahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Josselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Jeanneteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Turcq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Belloc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2012.01.004_bib1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2012.01.004_bib2","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood-2007-04-038943","article-title":"How I treat chronic myeloid leukemia in the imatinib era","volume":"110","author":"Goldman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.01.004_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.canlet.2010.10.018","article-title":"Imatinib treatment in chronic myelogenous leukemia: what have we learned so far?","volume":"300","author":"Breccia","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.exphem.2012.01.004_bib4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2012.01.004_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.cr.7310028","article-title":"How the Bcl-2 family of proteins interact to regulate apoptosis","volume":"16","author":"van Delft","year":"2006","journal-title":"Cell Res"},{"key":"10.1016\/j.exphem.2012.01.004_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ceb.2006.10.004","article-title":"How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane?","volume":"18","author":"Antignani","year":"2006","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.exphem.2012.01.004_bib7","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2008.26","article-title":"Contributions of the Raf\/MEK\/ERK, PI3K\/PTEN\/Akt\/mTOR and Jak\/STAT pathways to leukemia","volume":"22","author":"Steelman","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2012.01.004_bib8","doi-asserted-by":"crossref","first-page":"912","DOI":"10.4161\/cbt.6.6.4101","article-title":"Imatinib and nilotinib induce apoptosis of chronic myeloid leukemia cells through a Bim-dependant pathway modulated by cytokines","volume":"6","author":"Belloc","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.exphem.2012.01.004_bib9","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/cdd.2009.48","article-title":"Different forms of cell death induced by putative BCL2 inhibitors","volume":"16","author":"Vogler","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2012.01.004_bib10","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/cdd.2008.25","article-title":"A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells","volume":"15","author":"Vogler","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2012.01.004_bib11","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/sj.leu.2404719","article-title":"ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells","volume":"21","author":"Kline","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2012.01.004_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2141.2007.06899.x","article-title":"ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms","volume":"140","author":"Kuroda","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2012.01.004_bib13","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0606176103","article-title":"Bim and Bad mediate imatinib-induced killing of Bcr\/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic","volume":"103","author":"Kuroda","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2012.01.004_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrm830","article-title":"IAP proteins: blocking the road to death\u2019s door","volume":"3","author":"Salvesen","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2012.01.004_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/leu.2008.329","article-title":"Inhibitor of apoptosis proteins in hematological malignancies","volume":"23","author":"Fulda","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2012.01.004_bib16","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/leu.2010.212","article-title":"Smac mimetics: implications for enhancement of targeted therapies in leukemia","volume":"24","author":"Weisberg","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2012.01.004_bib17","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/sj.cdd.4400303","article-title":"Bcr-abl translocation can occur during the induction of multidrug resistance and confers apoptosis resistance on myeloid leukemic cell lines","volume":"4","author":"Belloc","year":"1997","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2012.01.004_bib18","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V96.3.1070","article-title":"Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance","volume":"96","author":"Mahon","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.01.004_bib19","doi-asserted-by":"crossref","first-page":"11752","DOI":"10.1073\/pnas.91.24.11752","article-title":"Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40","volume":"91","author":"Vayssiere","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2012.01.004_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1432-1033.1981.tb06218.x","article-title":"Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors","volume":"115","author":"Chou","year":"1981","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.exphem.2012.01.004_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0145-2126(96)00102-6","article-title":"Study of the apoptosis induced in\u00a0vitro by antitumoral drugs on leukaemic cells","volume":"21","author":"Vial","year":"1997","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2012.01.004_bib22","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1038\/sj.onc.1206004","article-title":"Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells","volume":"21","author":"Real","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2012.01.004_bib23","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/ijc.22977","article-title":"Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer","volume":"121","author":"Wesarg","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2012.01.004_bib24","doi-asserted-by":"crossref","first-page":"12815","DOI":"10.1073\/pnas.0707715105","article-title":"Executioner caspase-3 and caspase-7 are functionally distinct proteases","volume":"105","author":"Walsh","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2012.01.004_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0006-291X(03)00622-3","article-title":"Mammalian mitochondrial IAP binding proteins","volume":"304","author":"Vaux","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2012.01.004_bib26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.cdd.4401343","article-title":"Mitochondrial protease Omi\/HtrA2 enhances caspase activation through multiple pathways","volume":"11","author":"Suzuki","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2012.01.004_bib27","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1074\/jbc.M212819200","article-title":"Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi\/HtrA2","volume":"278","author":"Cilenti","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2012.01.004_bib28","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/sj.cdd.4402168","article-title":"Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia","volume":"14","author":"Kuroda","year":"2007","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.exphem.2012.01.004_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.leu.2404463","article-title":"Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia","volume":"21","author":"Pocaly","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2012.01.004_bib30","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood.V96.6.2246","article-title":"CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs","volume":"96","author":"Fang","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2012.01.004_bib31","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1046\/j.1471-4159.2002.01229.x","article-title":"A caspase-3-dependent pathway is predominantly activated by the excitotoxin pregnenolone sulfate and requires early and late cytochrome c release and cell-specific caspase-2 activation in the retinal cell death","volume":"83","author":"Cascio","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.exphem.2012.01.004_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1242\/jcs.00236","article-title":"Outer mitochondrial membrane permeabilization during apoptosis triggers caspase-independent mitochondrial and caspase-dependent plasma membrane potential depolarization: a single-cell analysis","volume":"116","author":"Dussmann","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.exphem.2012.01.004_bib33","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1590\/S0100-879X2006005000109","article-title":"A mechanistic view of mitochondrial death decision pores","volume":"40","author":"Belizario","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.exphem.2012.01.004_bib34","article-title":"Activation of apoptosis signaling eliminates CD34(+) progenitor cells in blast crisis CML independent of response to tyrosine kinase inhibitors","author":"Mak","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2012.01.004_bib35","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1038\/sj.leu.2402661","article-title":"Up-regulation of XIAP by M-CSF is associated with resistance of myeloid leukemia cells to apoptosis","volume":"16","author":"Zhang","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2012.01.004_bib36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2008.364","article-title":"The stem cell factor-c-KIT pathway must be inhibited to enable apoptosis induced by BCR-ABL inhibitors in chronic myelogenous leukemia cells","volume":"23","author":"Belloc","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2012.01.004_bib37","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa055104","article-title":"Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL","volume":"354","author":"Kantarjian","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2012.01.004_bib38","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1371\/journal.pmed.0040315","article-title":"BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations","volume":"4","author":"Costa","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.exphem.2012.01.004_bib39","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","article-title":"Programmed anuclear cell death delimits platelet life span","volume":"128","author":"Mason","year":"2007","journal-title":"Cell"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X12000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X12000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:29:38Z","timestamp":1759566578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X12000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0301472X12000069"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2012.01.004","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ABT-737 increases tyrosine kinase inhibitor\u2013induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34+ CD38\u2212 population to imatinib","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2012.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}